UTMD (Utah Medical Products Inc)
Insider Trading Activity
Every open-market purchase and sale reported by UTMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | PAUL O RICHINS | Director | G | — | — |
| 2026-05-29 | Brian Koopman | Principal Financial Officer | G | — | — |
| 2025-11-25 | Brian Koopman | Principal Financial Officer | A | — | — |
| 2025-09-05 | Brian Koopman | Principal Financial Officer | G | — | — |
| 2025-08-26 | PAUL O RICHINS | Director | G | — | — |
| 2024-11-08 | Brian Koopman | Principal Financial Officer | A | — | — |
| 2024-07-22 | Brian Koopman | Principal Financial Officer | G | — | — |
| 2024-05-17 | PAUL O RICHINS | Director | G | — | — |
| 2023-12-26 | Brian Koopman | Principal Financial Officer | A | — | — |
| 2023-06-20 | Brian Koopman | Principal Financial Officer | G | — | — |
| 2023-05-19 | PAUL O RICHINS | Director | Sell | — | — |
| 2023-03-17 | PAUL O RICHINS | Director | G | — | — |
| 2023-02-09 | BARBARA A PAYNE | Director | G | — | — |
| 2022-12-06 | Brian Koopman | Principal Financial Officer | MIXED | — | — |
| 2022-11-21 | PAUL O RICHINS | Director | Sell | — | — |
| 2022-11-17 | PAUL O RICHINS | Director | Sell | — | — |
| 2022-11-15 | PAUL O RICHINS | Director | Sell | — | — |
| 2022-11-03 | Brian Koopman | Principal Financial Officer | G | — | — |
| 2022-10-25 | Brian Koopman | Principal Financial Officer | A | — | — |
| 2022-06-27 | PAUL O RICHINS | Director | G | — | — |
| 2022-05-11 | BARBARA A PAYNE | Director | Sell | — | — |
| 2022-02-10 | BARBARA A PAYNE | Director | G | — | — |
| 2021-12-13 | PAUL O RICHINS | Director | M | — | — |
| 2021-11-26 | ERNST G HOYER | Director | Sell | — | — |
| 2021-11-23 | KEVIN L CORNWELL | Chairman, CEO, Secretary | G | — | — |
| 2021-11-18 | BARBARA A PAYNE | Director | Sell | — | — |
| 2021-10-28 | Brian Koopman | Principal Financial Officer | MIXED | — | — |
| 2021-10-28 | Brian Koopman | Principal Financial Officer | A | — | — |
| 2021-08-30 | BARBARA A PAYNE | Director | Sell | — | — |
| 2021-08-27 | BARBARA A PAYNE | Director | Sell | — | — |
| 2021-03-12 | PAUL O RICHINS | Director | G | — | — |
| 2021-03-10 | BARBARA A PAYNE | Director | Sell | — | — |
| 2021-02-09 | BARBARA A PAYNE | Director | G | — | — |
| 2020-06-09 | KEVIN L CORNWELL | Chairman, CEO, Secretary | Sell | — | — |
| 2020-06-05 | BARBARA A PAYNE | Director | Sell | — | — |
| 2020-06-05 | KEVIN L CORNWELL | Chairman, CEO, Secretary | Sell | — | — |
| 2020-06-04 | BARBARA A PAYNE | Director | Sell | — | — |
| 2020-05-28 | BARBARA A PAYNE | Director | Sell | — | — |
| 2020-05-28 | PAUL O RICHINS | Director | Sell | — | — |
| 2020-05-27 | BARBARA A PAYNE | Director | Sell | — | — |
| 2020-05-22 | BARBARA A PAYNE | Director | Sell | — | — |
| 2020-05-19 | BARBARA A PAYNE | Director | Sell | — | — |
| 2020-05-13 | PAUL O RICHINS | Director | G | — | — |
| 2020-05-11 | PAUL O RICHINS | Director | G | — | — |
| 2020-02-21 | BARBARA A PAYNE | Director | G | — | — |
| 2019-12-13 | KEVIN L CORNWELL | Chairman, CEO, Secretary | Sell | — | — |
| 2019-11-29 | KEVIN L CORNWELL | Chairman, CEO, Secretary | Sell | — | — |
| 2019-11-19 | BARBARA A PAYNE | Director | Sell | — | — |
| 2019-11-13 | BARBARA A PAYNE | Director | Sell | — | — |
| 2019-11-12 | BARBARA A PAYNE | Director | G | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman, CEO, Secretary | 188,472 | — |
| — | Director | 53,744 | — |
| — | Director | 43,144 | — |
| — | Director | 13,125 | — |
| — | Director | 4,838 | — |
| — | Principal Financial Officer | 782 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UTMD quote page; the site-wide leaderboard is on the insider transactions hub.